help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Remessy, A. B.
Right arrow Articles by Caldwell, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Remessy, A. B.
Right arrow Articles by Caldwell, R. B.
(American Journal of Pathology. 2003;162:1995-2004.)
© 2003 American Society for Investigative Pathology

Experimental Diabetes Causes Breakdown of the Blood-Retina Barrier by a Mechanism Involving Tyrosine Nitration and Increases in Expression of Vascular Endothelial Growth Factor and Urokinase Plasminogen Activator Receptor

Azza B. El-Remessy*{dagger}, M. Ali Behzadian*{dagger}, Gamal Abou-Mohamed{dagger}, Telina Franklin*, Robert W. Caldwell{dagger} and Ruth B. Caldwell*{ddagger}§

From the Vascular Biology Center* and the Departments of Pharmacology and Toxicology,{dagger} Cellular Biology and Anatomy,{ddagger} and Ophthalmology,§ Medical College of Georgia, Augusta, Georgia

The purpose of these experiments was to determine the specific role of reactive oxygen species (ROS) in the blood-retinal barrier (BRB) breakdown that characterizes the early stages of vascular dysfunction in diabetes. Based on our data showing that high glucose increases nitric oxide, superoxide, and nitrotyrosine formation in retinal endothelial cells, we hypothesized that excess formation of ROS causes BRB breakdown in diabetes. Because ROS are known to induce increases in expression of the well-known endothelial mitogen and permeability factor vascular endothelial growth factor (VEGF) we also examined their influence on the expression of VEGF and its downstream target urokinase plasminogen activator receptor (uPAR). After 2 weeks of streptozotocin-induced diabetes, analysis of albumin leakage confirmed a prominent breakdown of the BRB. This permeability defect was correlated with significant increases in the formation of nitric oxide, lipid peroxides, and the peroxynitrite biomarker nitrotyrosine as well as with increases in the expression of VEGF and uPAR. Treatment with a nitric oxide synthase inhibitor (N-{omega}-nitro-L-arginine methyl ester, 50 mg/kg/day) or peroxynitrite scavenger (uric acid, 160 mg/kg/day) blocked the breakdown in the BRB and prevented the increases in formation of lipid peroxides and tyrosine nitration as well as the increases in expression of VEGF and uPAR. Taken together, these data indicate that early diabetes causes breakdown of the BRB by a mechanism involving the action of reactive nitrogen species in promoting expression of VEGF and uPAR.




This article has been cited by other articles:


Home page
 IOVSHome page
M. Al-Shabrawey, M. Rojas, T. Sanders, A. Behzadian, A. El-Remessy, M. Bartoli, A. K. Parpia, G. Liou, and R. B. Caldwell
Role of NADPH Oxidase in Retinal Vascular Inflammation
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3239 - 3244.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Al-Shabrawey, M. Bartoli, A. B. El-Remessy, G. Ma, S. Matragoon, T. Lemtalsi, R. W. Caldwell, and R. B. Caldwell
Role of NADPH Oxidase and Stat3 in Statin-Mediated Protection against Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3231 - 3238.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy
Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes
Diabetes, April 1, 2008; 57(4): 889 - 898.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. C. Leal, A. Manivannan, K.-I. Hosoya, T. Terasaki, J. Cunha-Vaz, A. F. Ambrosio, and J. V. Forrester
Inducible Nitric Oxide Synthase Isoform Is a Key Mediator of Leukostasis and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5257 - 5265.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. B. El-Remessy, M. Al-Shabrawey, D. H. Platt, M. Bartoli, M. A. Behzadian, N. Ghaly, N. Tsai, K. Motamed, and R. B. Caldwell
Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells
FASEB J, August 1, 2007; 21(10): 2528 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Y.-J. Zhang, Y.-F. Xu, Y.-H. Liu, J. Yin, H.-L. Li, Q. Wang, and J.-Z. Wang
Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms
FASEB J, July 1, 2006; 20(9): 1431 - 1442.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, Y. Y. Sautin, O. Glushakova, B. Croker, M. A. Atkinson, C. C. Tisher, and R. J. Johnson
Uncoupling of Vascular Endothelial Growth Factor with Nitric Oxide as a Mechanism for Diabetic Vasculopathy
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 736 - 745.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. B. El-Remessy, M. Al-Shabrawey, Y. Khalifa, N.-T. Tsai, R. B. Caldwell, and G. I. Liou
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
Am. J. Pathol., January 1, 2006; 168(1): 235 - 244.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. K.H. Cheung, M. K.L. Fung, A. C.Y. Lo, T. T.L. Lam, K. F. So, S. S.M. Chung, and S. K. Chung
Aldose Reductase Deficiency Prevents Diabetes-Induced Blood-Retinal Barrier Breakdown, Apoptosis, and Glial Reactivation in the Retina of db/db Mice
Diabetes, November 1, 2005; 54(11): 3119 - 3125.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Al-Shabrawey, M. Bartoli, A. B. El-Remessy, D. H. Platt, S. Matragoon, M. A. Behzadian, R. W. Caldwell, and R. B. Caldwell
Inhibition of NAD(P)H Oxidase Activity Blocks Vascular Endothelial Growth Factor Overexpression and Neovascularization during Ischemic Retinopathy
Am. J. Pathol., August 1, 2005; 167(2): 599 - 607.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. B. El-Remessy, M. Bartoli, D. H. Platt, D. Fulton, and R. B. Caldwell
Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration
J. Cell Sci., January 1, 2005; 118(1): 243 - 252.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. R. Moreno and V. Fuster
New aspects in the pathogenesis of diabetic atherothrombosis
J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2293 - 2300.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. B. El-Remessy, I. E. Khalil, S. Matragoon, G. Abou-Mohamed, N.-J. Tsai, P. Roon, R. B. Caldwell, R. W. Caldwell, K. Green, and G. I. Liou
Neuroprotective Effect of(-){Delta}9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-D-Aspartate-Induced Retinal Neurotoxicity: Involvement of Peroxynitrite
Am. J. Pathol., November 1, 2003; 163(5): 1997 - 2008.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. B. El-Remessy, G. Abou-Mohamed, R. W. Caldwell, and R. B. Caldwell
High Glucose-Induced Tyrosine Nitration in Endothelial Cells: Role of eNOS Uncoupling and Aldose Reductase Activation
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3135 - 3143.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.